Chemed Price to Free Cash Flow Ratio 2010-2024 | CHE

Historical price to free cash flow ratio values for Chemed (CHE) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Chemed Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-11-19 547.34 26.31
2024-09-30 600.43 $20.81 28.86
2024-06-30 541.62 $16.83 32.18
2024-03-31 640.79 $19.87 32.25
2023-12-31 583.32 $18.03 32.35
2023-09-30 518.08 $17.06 30.37
2023-06-30 539.56 $18.52 29.13
2023-03-31 535.28 $13.91 38.47
2022-12-31 507.72 $16.88 30.08
2022-09-30 433.91 $14.56 29.81
2022-06-30 466.18 $18.45 25.27
2022-03-31 502.72 $-4.76 0.00
2021-12-31 524.65 $-6.23 0.00
2021-09-30 460.93 $-2.34 0.00
2021-06-30 469.86 $1.94 241.91
2020-12-31 526.63 $26.35 19.98
2020-09-30 474.63 $31.53 15.05
2020-06-30 445.40 $30.02 14.84
2020-03-31 427.46 $26.28 16.27
2019-12-31 433.11 $23.36 18.54
2021-03-31 455.01 $17.41 26.13
2019-09-30 411.40 $14.33 28.72
2019-06-30 355.25 $13.06 27.20
2019-03-31 314.82 $14.44 21.80
2018-12-31 278.38 $13.94 19.97
2018-09-30 313.76 $9.00 34.88
2018-06-30 315.65 $7.14 44.23
2018-03-31 267.41 $5.42 49.34
2017-12-31 237.91 $5.87 40.56
2017-09-30 197.56 $8.18 24.16
2017-06-30 199.70 $7.03 28.41
2017-03-31 178.14 $9.50 18.75
2016-12-31 156.19 $5.70 27.42
2016-09-30 137.10 $8.51 16.11
2016-06-30 132.23 $7.57 17.46
2016-03-31 131.16 $6.84 19.16
2015-12-31 144.79 $7.31 19.81
2015-09-30 128.80 $7.40 17.40
2015-06-30 126.30 $5.22 24.20
2015-03-31 114.83 $-2.58 0.00
2014-12-31 101.43 $-2.58 0.00
2014-09-30 98.57 $-2.73 0.00
2014-06-30 89.58 $1.29 69.38
2013-12-31 72.90 $6.54 11.15
2013-09-30 67.85 $12.40 5.47
2013-06-30 68.54 $8.81 7.78
2013-03-31 75.49 $5.89 12.82
2012-12-31 64.59 $7.70 8.39
2014-03-31 85.31 $1.53 55.79
2012-09-30 65.06 $5.52 11.79
2012-06-30 56.59 $7.11 7.96
2012-03-31 58.52 $4.86 12.04
2011-12-31 47.69 $6.91 6.90
2011-09-30 51.04 $4.94 10.33
2011-06-30 60.67 $3.93 15.43
2011-03-31 61.55 $4.49 13.71
2010-12-31 58.56 $2.62 22.34
2010-09-30 52.41 $4.85 10.82
2010-06-30 50.13 $4.88 10.27
2010-03-31 49.79 $5.21 9.56
2009-12-31 43.82 $6.13 7.15
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.238B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00